A population-based comparison of patients with metastatic esophagogastric carcinoma between Japan and the Netherlands
Purpose Differences exist between Asian and Western patients with esophagogastric cancer, for example in terms of histological subtype and treatment strategies. This study aimed to compare characteristics and treatment between patients with metastatic esophagogastric cancer from Japan and the Nether...
Gespeichert in:
| Veröffentlicht in: | Journal of cancer research and clinical oncology 2023-11, Vol.149 (14), p.13323-13330 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 13330 |
|---|---|
| container_issue | 14 |
| container_start_page | 13323 |
| container_title | Journal of cancer research and clinical oncology |
| container_volume | 149 |
| creator | Pape, Marieke Vissers, Pauline A. J. Kato, Ken Haj Mohammad, Nadia Klarenbeek, Bastiaan van Laarhoven, Hanneke W. M. Matsuda, Tomohiro Verhoeven, Rob H. A. |
| description | Purpose
Differences exist between Asian and Western patients with esophagogastric cancer, for example in terms of histological subtype and treatment strategies. This study aimed to compare characteristics and treatment between patients with metastatic esophagogastric cancer from Japan and the Netherlands using nationwide cancer registry data.
Methods
Patients diagnosed with metastatic esophageal or gastric cancer were included from the nationwide national cancer registry of Japan (2016–2019) and the Netherlands (2015–2020). Treatment strategies were analyzed using chi-squared tests.
Results
The proportion of patients with metastatic esophageal (16.0% vs 34.2%) and gastric cancer (14.9% vs 45.2%) were lower in Japan compared to the Netherlands. Japanese patients with metastatic esophageal adenocarcinoma (EAC), esophageal squamous cell carcinoma (ESCC) or gastric cancer (GC) were more often male and older compared to Dutch patients. Proportion of patients with metastatic disease who received surgical resection was higher in Japan compared to the Netherlands (EAC 9.3 vs 1.4%,
p
|
| doi_str_mv | 10.1007/s00432-023-05111-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10587097</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3153573390</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-34f36a5ee5eac40118e006f8aa4543e07d71d5f5479de3ca764cae64f1438fe03</originalsourceid><addsrcrecordid>eNqFUk1v1DAQtRCILoU_wAFZ4sIlMI7tODmhqoICquACZ2vWmeymSuxgO1T993jZUj4OcLE1M2_e-I0fY08FvBQA5lUCULKuoJYVaCFEpe6xjTikhJT6PtuAMKLStWhO2KOUrqDE2tQP2Yk0qm1kpzdsPeNLWNYJ8xh8tcVEPXdhXjCOKXgeBr6UEvmc-PWY93ymjCmXlOOUwrLHXdiVRCyxw-hGH2bkW8rXRJ5_wAU9R9_zvCf-kcoZpxKmx-zBgFOiJ7f3Kfvy9s3n83fV5aeL9-dnl5VTusuVVINsUBNpQqdAiJYAmqFFVFpJAtMb0etBK9P1JB2aRjmkRg1lCe1AIE_Z6yPvsm5n6l3REXGySxxnjDc24Gj_rPhxb3fhmxWgWwOdKQwvbhli-LpSynYek6OpyKCwJiuFltpI2cF_oXWrhAKloS3Q539Br8IafVlFQZm2E0XSgbA-olwMKUUa7h4uwB4cYI8OsMUB9ocDrCpNz36XfNfy88sLQB4BqZT8juKv2f-g_Q5BSb4D</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2878915470</pqid></control><display><type>article</type><title>A population-based comparison of patients with metastatic esophagogastric carcinoma between Japan and the Netherlands</title><source>SpringerLink Journals - AutoHoldings</source><creator>Pape, Marieke ; Vissers, Pauline A. J. ; Kato, Ken ; Haj Mohammad, Nadia ; Klarenbeek, Bastiaan ; van Laarhoven, Hanneke W. M. ; Matsuda, Tomohiro ; Verhoeven, Rob H. A.</creator><creatorcontrib>Pape, Marieke ; Vissers, Pauline A. J. ; Kato, Ken ; Haj Mohammad, Nadia ; Klarenbeek, Bastiaan ; van Laarhoven, Hanneke W. M. ; Matsuda, Tomohiro ; Verhoeven, Rob H. A.</creatorcontrib><description><![CDATA[Purpose
Differences exist between Asian and Western patients with esophagogastric cancer, for example in terms of histological subtype and treatment strategies. This study aimed to compare characteristics and treatment between patients with metastatic esophagogastric cancer from Japan and the Netherlands using nationwide cancer registry data.
Methods
Patients diagnosed with metastatic esophageal or gastric cancer were included from the nationwide national cancer registry of Japan (2016–2019) and the Netherlands (2015–2020). Treatment strategies were analyzed using chi-squared tests.
Results
The proportion of patients with metastatic esophageal (16.0% vs 34.2%) and gastric cancer (14.9% vs 45.2%) were lower in Japan compared to the Netherlands. Japanese patients with metastatic esophageal adenocarcinoma (EAC), esophageal squamous cell carcinoma (ESCC) or gastric cancer (GC) were more often male and older compared to Dutch patients. Proportion of patients with metastatic disease who received surgical resection was higher in Japan compared to the Netherlands (EAC 9.3 vs 1.4%,
p
< 0.001; ESCC 10.7% vs 2.3%,
p
< 0.001; GC 12.0% vs 3.6%
p
< 0.001). Proportion of patients who received systemic therapy was also higher (EAC 44.8% vs 30.4%,
p
< 0.001; ESCC 26.6% vs 12.0%,
p
< 0.001; GC 50.7% vs 35.8%
p
< 0.001).
Conclusions
Japanese patients less often presented with metastatic esophagogastric cancer and more often underwent surgical resection or received systemic therapy compared to Dutch patients. Further investigation should elucidate what the deliberations are in both Japan and the Netherlands and if more patients in the Netherlands could benefit from surgical resection or systemic therapy and whether this would translate in better survival and quality of life.]]></description><identifier>ISSN: 0171-5216</identifier><identifier>EISSN: 1432-1335</identifier><identifier>DOI: 10.1007/s00432-023-05111-4</identifier><identifier>PMID: 37486395</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adenocarcinoma ; Cancer Research ; Esophageal cancer ; Esophageal carcinoma ; Esophagus ; Gastric cancer ; Hematology ; histology ; Internal Medicine ; Japan ; males ; Medicine ; Medicine & Public Health ; Metastases ; Metastasis ; Netherlands ; Oncology ; Quality of life ; resection ; Squamous cell carcinoma ; stomach neoplasms</subject><ispartof>Journal of cancer research and clinical oncology, 2023-11, Vol.149 (14), p.13323-13330</ispartof><rights>The Author(s) 2023</rights><rights>2023. The Author(s).</rights><rights>The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c459t-34f36a5ee5eac40118e006f8aa4543e07d71d5f5479de3ca764cae64f1438fe03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00432-023-05111-4$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00432-023-05111-4$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37486395$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pape, Marieke</creatorcontrib><creatorcontrib>Vissers, Pauline A. J.</creatorcontrib><creatorcontrib>Kato, Ken</creatorcontrib><creatorcontrib>Haj Mohammad, Nadia</creatorcontrib><creatorcontrib>Klarenbeek, Bastiaan</creatorcontrib><creatorcontrib>van Laarhoven, Hanneke W. M.</creatorcontrib><creatorcontrib>Matsuda, Tomohiro</creatorcontrib><creatorcontrib>Verhoeven, Rob H. A.</creatorcontrib><title>A population-based comparison of patients with metastatic esophagogastric carcinoma between Japan and the Netherlands</title><title>Journal of cancer research and clinical oncology</title><addtitle>J Cancer Res Clin Oncol</addtitle><addtitle>J Cancer Res Clin Oncol</addtitle><description><![CDATA[Purpose
Differences exist between Asian and Western patients with esophagogastric cancer, for example in terms of histological subtype and treatment strategies. This study aimed to compare characteristics and treatment between patients with metastatic esophagogastric cancer from Japan and the Netherlands using nationwide cancer registry data.
Methods
Patients diagnosed with metastatic esophageal or gastric cancer were included from the nationwide national cancer registry of Japan (2016–2019) and the Netherlands (2015–2020). Treatment strategies were analyzed using chi-squared tests.
Results
The proportion of patients with metastatic esophageal (16.0% vs 34.2%) and gastric cancer (14.9% vs 45.2%) were lower in Japan compared to the Netherlands. Japanese patients with metastatic esophageal adenocarcinoma (EAC), esophageal squamous cell carcinoma (ESCC) or gastric cancer (GC) were more often male and older compared to Dutch patients. Proportion of patients with metastatic disease who received surgical resection was higher in Japan compared to the Netherlands (EAC 9.3 vs 1.4%,
p
< 0.001; ESCC 10.7% vs 2.3%,
p
< 0.001; GC 12.0% vs 3.6%
p
< 0.001). Proportion of patients who received systemic therapy was also higher (EAC 44.8% vs 30.4%,
p
< 0.001; ESCC 26.6% vs 12.0%,
p
< 0.001; GC 50.7% vs 35.8%
p
< 0.001).
Conclusions
Japanese patients less often presented with metastatic esophagogastric cancer and more often underwent surgical resection or received systemic therapy compared to Dutch patients. Further investigation should elucidate what the deliberations are in both Japan and the Netherlands and if more patients in the Netherlands could benefit from surgical resection or systemic therapy and whether this would translate in better survival and quality of life.]]></description><subject>Adenocarcinoma</subject><subject>Cancer Research</subject><subject>Esophageal cancer</subject><subject>Esophageal carcinoma</subject><subject>Esophagus</subject><subject>Gastric cancer</subject><subject>Hematology</subject><subject>histology</subject><subject>Internal Medicine</subject><subject>Japan</subject><subject>males</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Netherlands</subject><subject>Oncology</subject><subject>Quality of life</subject><subject>resection</subject><subject>Squamous cell carcinoma</subject><subject>stomach neoplasms</subject><issn>0171-5216</issn><issn>1432-1335</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFUk1v1DAQtRCILoU_wAFZ4sIlMI7tODmhqoICquACZ2vWmeymSuxgO1T993jZUj4OcLE1M2_e-I0fY08FvBQA5lUCULKuoJYVaCFEpe6xjTikhJT6PtuAMKLStWhO2KOUrqDE2tQP2Yk0qm1kpzdsPeNLWNYJ8xh8tcVEPXdhXjCOKXgeBr6UEvmc-PWY93ymjCmXlOOUwrLHXdiVRCyxw-hGH2bkW8rXRJ5_wAU9R9_zvCf-kcoZpxKmx-zBgFOiJ7f3Kfvy9s3n83fV5aeL9-dnl5VTusuVVINsUBNpQqdAiJYAmqFFVFpJAtMb0etBK9P1JB2aRjmkRg1lCe1AIE_Z6yPvsm5n6l3REXGySxxnjDc24Gj_rPhxb3fhmxWgWwOdKQwvbhli-LpSynYek6OpyKCwJiuFltpI2cF_oXWrhAKloS3Q539Br8IafVlFQZm2E0XSgbA-olwMKUUa7h4uwB4cYI8OsMUB9ocDrCpNz36XfNfy88sLQB4BqZT8juKv2f-g_Q5BSb4D</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Pape, Marieke</creator><creator>Vissers, Pauline A. J.</creator><creator>Kato, Ken</creator><creator>Haj Mohammad, Nadia</creator><creator>Klarenbeek, Bastiaan</creator><creator>van Laarhoven, Hanneke W. M.</creator><creator>Matsuda, Tomohiro</creator><creator>Verhoeven, Rob H. A.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><scope>5PM</scope></search><sort><creationdate>20231101</creationdate><title>A population-based comparison of patients with metastatic esophagogastric carcinoma between Japan and the Netherlands</title><author>Pape, Marieke ; Vissers, Pauline A. J. ; Kato, Ken ; Haj Mohammad, Nadia ; Klarenbeek, Bastiaan ; van Laarhoven, Hanneke W. M. ; Matsuda, Tomohiro ; Verhoeven, Rob H. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-34f36a5ee5eac40118e006f8aa4543e07d71d5f5479de3ca764cae64f1438fe03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adenocarcinoma</topic><topic>Cancer Research</topic><topic>Esophageal cancer</topic><topic>Esophageal carcinoma</topic><topic>Esophagus</topic><topic>Gastric cancer</topic><topic>Hematology</topic><topic>histology</topic><topic>Internal Medicine</topic><topic>Japan</topic><topic>males</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Netherlands</topic><topic>Oncology</topic><topic>Quality of life</topic><topic>resection</topic><topic>Squamous cell carcinoma</topic><topic>stomach neoplasms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pape, Marieke</creatorcontrib><creatorcontrib>Vissers, Pauline A. J.</creatorcontrib><creatorcontrib>Kato, Ken</creatorcontrib><creatorcontrib>Haj Mohammad, Nadia</creatorcontrib><creatorcontrib>Klarenbeek, Bastiaan</creatorcontrib><creatorcontrib>van Laarhoven, Hanneke W. M.</creatorcontrib><creatorcontrib>Matsuda, Tomohiro</creatorcontrib><creatorcontrib>Verhoeven, Rob H. A.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cancer research and clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pape, Marieke</au><au>Vissers, Pauline A. J.</au><au>Kato, Ken</au><au>Haj Mohammad, Nadia</au><au>Klarenbeek, Bastiaan</au><au>van Laarhoven, Hanneke W. M.</au><au>Matsuda, Tomohiro</au><au>Verhoeven, Rob H. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A population-based comparison of patients with metastatic esophagogastric carcinoma between Japan and the Netherlands</atitle><jtitle>Journal of cancer research and clinical oncology</jtitle><stitle>J Cancer Res Clin Oncol</stitle><addtitle>J Cancer Res Clin Oncol</addtitle><date>2023-11-01</date><risdate>2023</risdate><volume>149</volume><issue>14</issue><spage>13323</spage><epage>13330</epage><pages>13323-13330</pages><issn>0171-5216</issn><eissn>1432-1335</eissn><abstract><![CDATA[Purpose
Differences exist between Asian and Western patients with esophagogastric cancer, for example in terms of histological subtype and treatment strategies. This study aimed to compare characteristics and treatment between patients with metastatic esophagogastric cancer from Japan and the Netherlands using nationwide cancer registry data.
Methods
Patients diagnosed with metastatic esophageal or gastric cancer were included from the nationwide national cancer registry of Japan (2016–2019) and the Netherlands (2015–2020). Treatment strategies were analyzed using chi-squared tests.
Results
The proportion of patients with metastatic esophageal (16.0% vs 34.2%) and gastric cancer (14.9% vs 45.2%) were lower in Japan compared to the Netherlands. Japanese patients with metastatic esophageal adenocarcinoma (EAC), esophageal squamous cell carcinoma (ESCC) or gastric cancer (GC) were more often male and older compared to Dutch patients. Proportion of patients with metastatic disease who received surgical resection was higher in Japan compared to the Netherlands (EAC 9.3 vs 1.4%,
p
< 0.001; ESCC 10.7% vs 2.3%,
p
< 0.001; GC 12.0% vs 3.6%
p
< 0.001). Proportion of patients who received systemic therapy was also higher (EAC 44.8% vs 30.4%,
p
< 0.001; ESCC 26.6% vs 12.0%,
p
< 0.001; GC 50.7% vs 35.8%
p
< 0.001).
Conclusions
Japanese patients less often presented with metastatic esophagogastric cancer and more often underwent surgical resection or received systemic therapy compared to Dutch patients. Further investigation should elucidate what the deliberations are in both Japan and the Netherlands and if more patients in the Netherlands could benefit from surgical resection or systemic therapy and whether this would translate in better survival and quality of life.]]></abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>37486395</pmid><doi>10.1007/s00432-023-05111-4</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0171-5216 |
| ispartof | Journal of cancer research and clinical oncology, 2023-11, Vol.149 (14), p.13323-13330 |
| issn | 0171-5216 1432-1335 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10587097 |
| source | SpringerLink Journals - AutoHoldings |
| subjects | Adenocarcinoma Cancer Research Esophageal cancer Esophageal carcinoma Esophagus Gastric cancer Hematology histology Internal Medicine Japan males Medicine Medicine & Public Health Metastases Metastasis Netherlands Oncology Quality of life resection Squamous cell carcinoma stomach neoplasms |
| title | A population-based comparison of patients with metastatic esophagogastric carcinoma between Japan and the Netherlands |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T21%3A23%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20population-based%20comparison%20of%20patients%20with%20metastatic%20esophagogastric%20carcinoma%20between%20Japan%20and%20the%20Netherlands&rft.jtitle=Journal%20of%20cancer%20research%20and%20clinical%20oncology&rft.au=Pape,%20Marieke&rft.date=2023-11-01&rft.volume=149&rft.issue=14&rft.spage=13323&rft.epage=13330&rft.pages=13323-13330&rft.issn=0171-5216&rft.eissn=1432-1335&rft_id=info:doi/10.1007/s00432-023-05111-4&rft_dat=%3Cproquest_pubme%3E3153573390%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2878915470&rft_id=info:pmid/37486395&rfr_iscdi=true |